









市場行情
/
股票
/
nasdaq-ccel
/

Cryo-Cell International Inc

CCEL

3.750USD

0.000

收盤 12/19, 16:00（美東）報價延遲15分鐘

30.21M總市值

虧損本益比TTM



Cryo-Cell International Inc

3.750

0.000

概覽公司財務分析

概覽

公司

財務

分析

關於 Cryo-Cell International Inc 公司

Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.

Cryo-Cell International Inc簡介



公司代碼CCEL

公司名稱Cryo-Cell International Inc

上市日期Apr 04, 1994

CEOPortnoy (Mark L)

員工數量82

證券類型Ordinary Share

年結日Apr 04

公司地址700 Brooker Creek Blvd

城市OLDSMAR

上市交易所NASDAQ OMX – NASDAQ Basic Amex

國家United States of America

郵編34677

電話18137492104

網址https://www.cryo-cell.com/

公司代碼CCEL

上市日期Apr 04, 1994

CEOPortnoy (Mark L)

Cryo-Cell International Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. David I. Portnoy

Chairman of the Board, Co-Chief Executive Officer

1.70M

+0.93%

Mr. Oleg Mikulinsky

Chief Information Officer

104.35K

Mr. Harold D. Berger, CPA

Independent Director

57.90K

Ms. Jill M. Taymans

Chief Financial Officer, Vice President - Finance

45.40K

Mr. Daniel Mizrahi

Independent Director

30.63K

Ms. Irene Smith

Executive Assistant / Office Manager

Mr. Mark L. Portnoy

Co-Chief Executive Officer, Director

名稱

名稱/職務

職務

持股

持股變動

Mr. David I. Portnoy

Chairman of the Board, Co-Chief Executive Officer

1.70M

+0.93%

Mr. Oleg Mikulinsky

Chief Information Officer

104.35K

Mr. Harold D. Berger, CPA

Independent Director

57.90K

Ms. Jill M. Taymans

Chief Financial Officer, Vice President - Finance

45.40K

Mr. Daniel Mizrahi

Independent Director

30.63K

Ms. Irene Smith

Executive Assistant / Office Manager

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Processing and storage fees

7.87M

99.28%

Public banking revenue

42.69K

0.54%

Product revenue

14.44K

0.18%

由於公司未披露，未能獲取相關數據

業務

地區

業務USD

名稱

營收

佔比

Processing and storage fees

7.87M

99.28%

Public banking revenue

42.69K

0.54%

Product revenue

14.44K

0.18%

股東統計

更新時間: 11月17日週一

持股股東

股東類型

持股股東

佔比

Portnoy (David I)

21.08%

Portnoy (Mark)

11.62%

Fleishman (Adam)

6.32%

Hamilton Lane Advisors, LLC

5.09%

SFI Advisors LLC

2.05%

其他

53.84%

持股股東

佔比

Portnoy (David I)

21.08%

Portnoy (Mark)

11.62%

Fleishman (Adam)

6.32%

Hamilton Lane Advisors, LLC

5.09%

SFI Advisors LLC

2.05%

其他

53.84%

股東類型

持股股東

佔比

Individual Investor

41.98%

Investment Advisor

6.16%

Private Equity

5.09%

Investment Advisor/Hedge Fund

0.74%

Hedge Fund

0.28%

其他

45.74%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

988.98K

13.06%

2025Q3

988.98K

13.05%

-7.47K

2025Q2

996.45K

12.94%

-34.34K

2025Q1

1.03M

12.77%

-1.40K

2024Q4

1.03M

13.60%

+129.95K

2024Q3

901.35K

13.54%

+4.71K

2024Q2

896.63K

13.23%

+22.67K

2024Q1

873.96K

13.34%

-231.88K

2023Q4

864.43K

13.53%

+21.68K

2023Q3

862.32K

13.61%

+13.39K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Portnoy (David I)

1.68M

20.81%

+107.02K

+6.81%

Sep 18, 2025

Portnoy (Mark)

935.77K

11.61%

Sep 15, 2025

Fleishman (Adam)

509.00K

6.31%

Sep 15, 2025

Hamilton Lane Advisors, LLC

409.73K

5.08%

Sep 30, 2025

SFI Advisors LLC

165.30K

2.05%

Jun 30, 2025

The Vanguard Group, Inc.

129.81K

1.61%

+11.58K

+9.79%

Jun 30, 2025

The MassMutual Trust Company, FSB

111.03K

1.38%

Jun 30, 2025

Mikulinsky (Oleg)

104.35K

1.29%

Sep 15, 2025

Berger (Harold D)

57.90K

0.72%

Sep 15, 2025

Geode Capital Management, L.L.C.

45.83K

0.57%

+601.00

+1.33%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

iShares Micro-Cap ETF

佔比0%

分紅派息



近5年累計派現 9.69M 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

May 08, 2025

CCEL.NB Interim Cash Dividend of gross USD 0.15 paid on May 30, 2025 going ex on May 21, 2025

May 21, 2025

May 30, 2025

May 21, 2025

Jan 29, 2025

CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Feb 28, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Feb 28, 2025

Feb 14, 2025

Oct 31, 2024

CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Nov 29, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Nov 29, 2024

Nov 15, 2024

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Cryo-Cell International Inc的前五大股東是誰？



Cryo-Cell International Inc的前五大股東如下：
Portnoy (David I)
持有股份：1.68M
佔總股份比例：20.81%。
Portnoy (Mark)
持有股份：935.77K
佔總股份比例：11.61%。
Fleishman (Adam)
持有股份：509.00K
佔總股份比例：6.31%。
Hamilton Lane Advisors, LLC
持有股份：409.73K
佔總股份比例：5.08%。
SFI Advisors LLC
持有股份：165.30K
佔總股份比例：2.05%。